Clinical research on treatment of severe aplastic anemia by anti-thymocyte globulin,cyclosporine A,androgenic hormone and hemopoietic growth factor
ZHANG Yuan
GUO Zhi
HE Xue-peng
LIU Xiao-dong
LIU Dan
CHENG Hui-ren
Abstract：Objective To observe the effectiveness and safety of the therapy of severe aplastic anemia (SAA)with antithymocyte globulin(ALG)association cyclosporine,androgenic hormone and hemopoietic growth factor Methods Clinical data of 21 patients with severe aplastic anemia who received the treatment of ALG,cyclosporine,androgenic hormone and hemopoietic growth factor from January 2003 to December 2007 were analyzed retrospectively. Results Of the 21 patients,3 persons were nearly cured and 4 were relieved.Seven individuals were improved and 14 patients were invalid.The overall effective rate was 66.7%. Conclusions The combination therapy of ATG,cyclosporin A,androgenic hormone and hemopoietic growth factor is effective and safe.It's an important therapy on SAA.
Keywords：AnemiaaplasticGlobulinsCyclosporine
Publication Date：2010-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)